184 related articles for article (PubMed ID: 27183437)
1. A Freeze-Dried Kit for the Preparation of (188)Re-HEDP for Bone Pain Palliation: Preparation and Preliminary Clinical Evaluation.
Mallia MB; Shinto AS; Kameswaran M; Kamaleshwaran KK; Kalarikal R; Aswathy KK; Banerjee S
Cancer Biother Radiopharm; 2016 May; 31(4):139-44. PubMed ID: 27183437
[TBL] [Abstract][Full Text] [Related]
2. Rhenium-188 Hydroxyethane 1,1-Diphosphonic Acid (HEDP) for Bone Pain Palliation Using BARC-HEDP Kits versus Pars-HEDP Kits: A Comparison on Preparation and Performance Aspects at Hospital Radiopharmacy.
Ramakurup REK; Chirayil V; Pandiyan A; Mallia MB; Kameswaran M; Shinto A; Dash A
Indian J Nucl Med; 2018; 33(4):302-305. PubMed ID: 30386051
[TBL] [Abstract][Full Text] [Related]
3. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Evaluation of
Sharma R; Kumar C; Mallia MB; Kameswaran M; Sarma HD; Banerjee S; Dash A
Cancer Biother Radiopharm; 2017 Jun; 32(5):184-191. PubMed ID: 28598690
[TBL] [Abstract][Full Text] [Related]
5. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
[TBL] [Abstract][Full Text] [Related]
6. Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
ter Heine R; Lange R; Breukels OB; Bloemendal HJ; Rummenie RG; Wakker AM; de Graaf H; Beekman FJ; van der Westerlaken MM; Malingré MM; Wielders JP; van den Berg L; Hendrikse NH; de Klerk JM
Int J Pharm; 2014 Apr; 465(1-2):317-24. PubMed ID: 24560635
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
Pirayesh E; Amoui M; Mirzaee HR; Tabei F; Rakhsha A; Kalantari BA; Shafiei B; Assadi M; Asli IN
J Nucl Med Technol; 2013 Sep; 41(3):192-6. PubMed ID: 23918612
[TBL] [Abstract][Full Text] [Related]
8. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Liepe K; Kropp J; Hliscs R; Franke WG
Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
[TBL] [Abstract][Full Text] [Related]
9. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
Lange R; Overbeek F; de Klerk JM; Pasker-de Jong PC; van den Berk AM; Ter Heine R; Rodenburg CJ; Kooistra A; Hendrikse NH; Bloemendal HJ
Nuklearmedizin; 2016 Sep; 55(5):188-95. PubMed ID: 27443809
[TBL] [Abstract][Full Text] [Related]
10. The tolerance and therapeutic efficacy of rhenium-188 hydroxyethylidene diphosphonate in advanced cancer patients with painful osseous metastases.
Cheng A; Chen S; Zhang Y; Yin D; Dong M
Cancer Biother Radiopharm; 2011 Apr; 26(2):237-44. PubMed ID: 21539455
[TBL] [Abstract][Full Text] [Related]
11. Application of rhenium-188 HEDP in bone metastases therapy.
Scheffler J; Derejko M; Bandurski T; Romanowicz G
Nucl Med Rev Cent East Eur; 2003; 6(1):55-7. PubMed ID: 14600935
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
[TBL] [Abstract][Full Text] [Related]
13. 186Re-HEDP for metastatic bone pain in breast cancer patients.
Lam MG; de Klerk JM; van Rijk PP
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846
[TBL] [Abstract][Full Text] [Related]
14. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
[TBL] [Abstract][Full Text] [Related]
15. Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases.
Limouris GS; Shukla SK; Condi-Paphiti A; Gennatas C; Kouvaris I; Vitoratos N; Manetou A; Dardoufas C; Rigas V; Vlahos L
Anticancer Res; 1997; 17(3B):1767-72. PubMed ID: 9179232
[TBL] [Abstract][Full Text] [Related]
16. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
Küçük NO; Ibiş E; Aras G; Baltaci S; Ozalp G; Bedük Y; Canakci N; Soylu A
Ann Nucl Med; 2000 Aug; 14(4):239-45. PubMed ID: 11023023
[TBL] [Abstract][Full Text] [Related]
17. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL
Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
[TBL] [Abstract][Full Text] [Related]
18. Applying quality by design principles to the small-scale preparation of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDP.
Lange R; Ter Heine R; van der Gronde T; Selles S; de Klerk J; Bloemendal H; Hendrikse H
Eur J Pharm Sci; 2016 Jul; 90():96-101. PubMed ID: 26772897
[TBL] [Abstract][Full Text] [Related]
19. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Palmedo H; Grünwald F; Wagner U; Köhler S; Krebs D; Biersack HJ
Clin Nucl Med; 1998 Aug; 23(8):501-4. PubMed ID: 9712380
[TBL] [Abstract][Full Text] [Related]
20. Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes.
Lin WY; Hsieh JF; Lin CP; Hsieh BT; Ting G; Wang SJ; Knapp FF
Nucl Med Biol; 1999 May; 26(4):455-9. PubMed ID: 10382850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
